Roche's lebrikizumab significantly reduced the rate of asthma attacks in patients with a severe form of the disease, according to mid-stage trial results, lighting the way for a Phase III study on the novel, personalized treatment.
Researchers believe they've come up with a new biomarker blood test that can diagnose heart attack much more quickly than existing tests allow and thereby reduce the potential for long-term harm.
Fluidigm and DVS Sciences announced Wednesday they're merging in a tie-up for which Fluidigm will pay $207.5 million in stock and cash to buy out its San Francisco Bay-area neighbor.
U.K. researchers believe they've come up with a rapid blood test that could detect sepsis at a patient's bedside, enabling quicker treatment of the severe and sometimes fatal infection.
Biomarkers are becoming increasingly useful to doctors as a tool to help diagnose patients earlier, predict the course of disease and tailor more individualized treatment regimens.
Med tech giant Agilent has signed a deal with SomaLogic to expand access to that company's protein biomarker discovery platform.
Medtronic has developed a first-of-its-kind implant, pairing traditional deep-brain stimulation with sensing technology, and, after performing its first procedure, the company says the device has a chance to change the standard of care for neurological disorders.
A research team with the UC Davis MIND Institute believes an excess of cerebrospinal fluid and enlarged brain size in infancy could be two biomarkers for autism.
U.K. researchers say they've come up with a viable bladder cancer test that detects biomarkers for the disease through urine odor.
Cancer cells smell, emitting gases laced with biomarkers revealing volatile organic compounds, and, with the right technology, breaking down that odor can help diagnose bladder cancer, according to a study.